-
公开(公告)号：US20050037968A1
公开(公告)日：2005-02-17
申请号：US10932004
申请日：2004-09-02
申请人： Jun Takasaki , Masazumi Kamohara , Mitsuyuki Matsumoto , Tetsu Saito , Tohru Sugimoto , Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai
发明人： Jun Takasaki , Masazumi Kamohara , Mitsuyuki Matsumoto , Tetsu Saito , Tohru Sugimoto , Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai
IPC分类号： A61K38/00 , A61P9/08 , A61P43/00 , C07K14/705 , C12N15/12 , G01N33/68 , G01N33/53 , A61K38/17
CPC分类号： C07K14/705 , A61K38/00 , G01N33/6893 , G01N2500/00 , G01N2500/04
摘要： A cDNA encoding a novel LTC4 receptor has been isolated. Provision of the novel protein, an LTC4 receptor, enabled binding experiments using the LTC4. By screening for compounds that modulate LTC4 receptor activity based on these binding experiments, development of drugs targeting the LTC4 receptor becomes possible.
-
公开(公告)号：US07217800B2
公开(公告)日：2007-05-15
申请号：US10932004
申请日：2004-09-02
申请人： Jun Takasaki , Masazumi Kamohara , Mitsuyuki Matsumoto , Tetsu Saito , Tohru Sugimoto , Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai
发明人： Jun Takasaki , Masazumi Kamohara , Mitsuyuki Matsumoto , Tetsu Saito , Tohru Sugimoto , Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai
IPC分类号： C07K16/28
CPC分类号： C07K14/705 , A61K38/00 , G01N33/6893 , G01N2500/00 , G01N2500/04
摘要： A cDNA encoding a novel LTC4 receptor has been isolated. Provision of the novel protein, an LTC4 receptor, enabled binding experiments using the LTC4. By screening for compounds that modulate LTC4 receptor activity based on these binding experiments, development of drugs targeting the LTC4 receptor becomes possible.
摘要翻译： 已经分离了编码新型LTC4受体的cDNA。 提供新的蛋白质，LTC4受体，能够使用LTC4N4进行结合实验。 通过基于这些结合实验筛选调节LTC4受体活性的化合物，开发靶向LTC4受体的药物成为可能。
-
公开(公告)号：US06878525B1
公开(公告)日：2005-04-12
申请号：US09979603
申请日：2000-09-13
申请人： Jun Takasaki , Masazumi Kamohara , Mitsuyuki Matsumoto , Tetsu Saito , Tohru Sugimoto , Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai
发明人： Jun Takasaki , Masazumi Kamohara , Mitsuyuki Matsumoto , Tetsu Saito , Tohru Sugimoto , Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai
IPC分类号： A61K38/00 , A61P9/08 , A61P43/00 , C07K14/705 , C12N15/12 , G01N33/68 , G01N33/567
CPC分类号： C07K14/705 , A61K38/00 , G01N33/6893 , G01N2500/00 , G01N2500/04
摘要： A cDNA encoding a novel LTC4 receptor has been isolated. Provision of the novel protein, an LTC4 receptor, enabled binding experiments using the LTC4. By screening for compounds that modulate LTC4 receptor activity based on these binding experiments, development of drugs targeting the LTC4 receptor becomes possible.
摘要翻译： 已经分离出编码新的LTC4受体的cDNA。 提供新的蛋白质LTC4受体，启用使用LTC4的结合实验。 通过筛选基于这些结合实验调节LTC4受体活性的化合物，开发靶向LTC4受体的药物成为可能。
-
公开(公告)号：US20070082345A1
公开(公告)日：2007-04-12
申请号：US11429594
申请日：2006-05-08
申请人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai , Tomoyasu Sugiyama , Koji Hayashi
发明人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai , Tomoyasu Sugiyama , Koji Hayashi
CPC分类号： C07K14/505 , C07K14/47
摘要： Novel human secretory proteins or membrane proteins, and full length cDNAs encoding the proteins are provided. 173 kinds of novel proteins and polynucleotides encoding these proteins have been isolated. The proteins of the present invention are useful as candidates for medicines or as target molecules for developing medicines. The polynucleotides of the present invention are used to produce these proteins.
摘要翻译： 提供新的人类分泌蛋白或膜蛋白，以及编码蛋白质的全长cDNA。 已经分离了173种新型蛋白质和编码这些蛋白质的多核苷酸。 本发明的蛋白质可用作药物的候选物或用作开发药物的靶分子。 本发明的多核苷酸用于制备这些蛋白质。
-
公开(公告)号：US07129338B1
公开(公告)日：2006-10-31
申请号：US10305278
申请日：2002-11-27
申请人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai , Tomoyasu Sugiyama , Koji Hayashi
发明人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Kawai , Tomoyasu Sugiyama , Koji Hayashi
IPC分类号： C07H19/167 , C07H19/173
CPC分类号： C07K14/47 , C07K14/505
摘要： Human cDNA encoding a secretory or membrane protein useful as a candidate for developing medicine or as a target molecule for developing medicine. The expression level of the polynucleotide of the present invention increased in NT2 cells after retinoic acid-treatment. Accordingly, this cDNA is associated neurological disease.
摘要翻译： 编码分泌蛋白或膜蛋白的人类cDNA可用作开发药物或用作开发药物的靶分子。 在视黄酸处理后，本发明的多核苷酸的表达量在NT2细胞中增加。 因此，该cDNA与神经系统疾病相关。
-
公开(公告)号：US20050250144A1
公开(公告)日：2005-11-10
申请号：US11109156
申请日：2005-04-19
申请人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Koji Hayashi , Kaoru Otsuka , Jun-Ichi Yamamoto , Shizuko Ishii , Tomoyasu Sugiyama , Ai Wakamatsu , Keiichi Nagai , Tetsuji Otsuki , Shin-Ichi Funahashi , Chiaki Senoo , Jin-Ichi Nezu
发明人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Koji Hayashi , Kaoru Otsuka , Jun-Ichi Yamamoto , Shizuko Ishii , Tomoyasu Sugiyama , Ai Wakamatsu , Keiichi Nagai , Tetsuji Otsuki , Shin-Ichi Funahashi , Chiaki Senoo , Jin-Ichi Nezu
IPC分类号： A61K38/00 , C07K14/47 , C12N1/15 , C12N1/19 , C12N1/21 , C12N15/12 , C12Q1/68 , C07H21/04 , C12N9/12 , C12N9/16 , C12N15/09 , C12P21/06
CPC分类号： C07K14/4702 , A61K38/00 , A61K2039/505 , A61K2039/53 , C07K14/47 , C12N2799/021
摘要： Selection of clones having the kinase and/or phosphatase-like structure from clones which had been isolated and the structures thereof had been determined in the Helix Research Institute (helix clones; Japanese Patent Application No. 2000-183767) was conducted. Two novel genes were provided by carrying out homology search for all the helix clones by using the amino acid sequences of known kinases and phosphatases as queries. The genes are expected to be involved in intracellular signal transduction. The physiological functions of the inventive genes can be tested by using reporter gene assay systems capable of detecting signal transduction. The proteins of the present invention are useful as target molecules in drug discovery and in the development of new pharmaceuticals.
摘要翻译： 已经在螺旋研究所（螺旋克隆，日本专利申请2000-183767）中确定了已经分离的克隆的克隆和/或磷酸酶样结构的克隆及其结构的选择。 通过使用已知的激酶和磷酸酶的氨基酸序列作为查询，通过对所有螺旋克隆进行同源性检索来提供两个新基因。 这些基因预期参与细胞内信号转导。 可以通过使用能够检测信号转导的报告基因测定系统来测试本发明基因的生理功能。 本发明的蛋白质可用作药物发现和开发新药物中的靶分子。
-
7.发明申请公开(公告)号：US20080069826A1
公开(公告)日：2008-03-20
申请号：US11869267
申请日：2007-10-09
申请人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Koji Hayashi , Kaoru Otsuka , Jun-Ichi Yamamoto , Shizuko Ishii , Tomoyasu Sugiyama , Ai Wakamatsu , Keiichi Nagai , Tetsuji Otsuki , Shin-Ichi Funahashi , Shoji Miyata , Kenji Sobue , Kenichiro Hayashi
发明人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Koji Hayashi , Kaoru Otsuka , Jun-Ichi Yamamoto , Shizuko Ishii , Tomoyasu Sugiyama , Ai Wakamatsu , Keiichi Nagai , Tetsuji Otsuki , Shin-Ichi Funahashi , Shoji Miyata , Kenji Sobue , Kenichiro Hayashi
CPC分类号： C07K16/18 , A61K38/00 , A61K2039/505 , A61K2039/53 , C07K14/47 , C07K14/4702 , C12N2799/021
摘要： A cDNA fragment participating in the maintenance of smooth muscle differentiation was isolated using a culture system of chicken gizzard smooth muscle cells, the differential display method and the subtracted hybridization method. Using the obtained cDNA sequence as a query, cDNA sequences of Helix Research Institute (Japanese Patent Application No. 2000-118776) were retrieved, and thus, a novel gene “C-NT2RP3001495” was obtained. The protein encoded by this gene has two WW domains that participate in protein interactions in the N-terminal domain. Evidence suggests that this protein binds to other proteins, and thus regulates the intracellular signal transduction, gene expression, and so on, thereby participating in the maintenance of the differentiation of smooth muscle cells. This protein and compounds regulating the expression thereof are markedly useful in developing drugs for various diseases associated with abnormality in the maintenance of smooth muscle cell differentiation.
摘要翻译： 使用鸡ard平滑肌细胞培养系统，差异显示法和减法杂交法分离参与维持平滑肌分化的cDNA片段。 使用获得的cDNA序列作为查询，检索Helix研究所的cDNA序列（日本专利申请2000-118776），从而得到新的基因“C-NT2RP3001495”。 由该基因编码的蛋白质具有参与N末端结构域中的蛋白质相互作用的两个WW结构域。 证据表明，该蛋白质与其他蛋白质结合，从而调节细胞内信号转导，基因表达等，从而参与维持平滑肌细胞的分化。 该蛋白质和调节其表达的化合物在开发用于维持平滑肌细胞分化异常的各种疾病的药物中显着有用。
-
公开(公告)号：US07029860B2
公开(公告)日：2006-04-18
申请号：US11013400
申请日：2004-12-17
申请人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Hio , Mayako Yamazaki , Susumu Satoh , Hiroyuki Arakawa , Masahiko Morita
发明人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Hio , Mayako Yamazaki , Susumu Satoh , Hiroyuki Arakawa , Masahiko Morita
IPC分类号： G01N33/50 , A61K38/17 , C07K14/435
CPC分类号： C07K14/4702 , A01K2217/05 , A61K38/00 , C07K14/4711 , C07K14/4747 , C07K14/505 , C07K14/524
摘要： The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-β protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-β protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-β protein.
摘要翻译： 本发明提供：抑制或促进淀粉样蛋白-β蛋白的聚集或沉积的蛋白质; 编码蛋白质的多核苷酸; 筛选抑制或促进淀粉样蛋白-β蛋白的聚集或沉积的化合物的方法; 以及用于治疗或预防阿尔茨海默病的治疗剂，其包含调节蛋白质抑制或促进淀粉样蛋白-β蛋白的聚集或沉积的活性的化合物。
-
9.发明授权公开(公告)号：US08110662B2
公开(公告)日：2012-02-07
申请号：US11869267
申请日：2007-10-09
申请人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Koji Hayashi , Kaoru Otsuka , Jun-Ichi Yamamoto , Shizuko Ishii , Tomoyasu Sugiyama , Ai Wakamatsu , Keiichi Nagai , Tetsuji Otsuki , Shin-Ichi Funahashi , Shoji Miyata , Kenji Sobue , Kenichiro Hayashi
发明人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Koji Hayashi , Kaoru Otsuka , Jun-Ichi Yamamoto , Shizuko Ishii , Tomoyasu Sugiyama , Ai Wakamatsu , Keiichi Nagai , Tetsuji Otsuki , Shin-Ichi Funahashi , Shoji Miyata , Kenji Sobue , Kenichiro Hayashi
CPC分类号： C07K16/18 , A61K38/00 , A61K2039/505 , A61K2039/53 , C07K14/47 , C07K14/4702 , C12N2799/021
摘要： A cDNA fragment participating in the maintenance of smooth muscle differentiation was isolated using a culture system of chicken gizzard smooth muscle cells, the differential display method and the subtracted hybridization method. Using the obtained cDNA sequence as a query, cDNA sequences of Helix Research Institute (Japanese Patent Application No. 2000-118776) were retrieved, and thus, a novel gene “C-NT2RP3001495” was obtained. The protein encoded by this gene has two WW domains that participate in protein interactions in the N-terminal domain. Evidence suggests that this protein binds to other proteins, and thus regulates the intracellular signal transduction, gene expression, and so on, thereby participating in the maintenance of the differentiation of smooth muscle cells. This protein and compounds regulating the expression thereof are markedly useful in developing drugs for various diseases associated with abnormality in the maintenance of smooth muscle cell differentiation.
摘要翻译： 使用鸡ard平滑肌细胞培养系统，差异显示法和减法杂交法分离参与维持平滑肌分化的cDNA片段。 使用获得的cDNA序列作为查询，检索Helix研究所的cDNA序列（日本专利申请2000-118776），从而得到新的基因“C-NT2RP3001495”。 由该基因编码的蛋白质具有参与N末端结构域中的蛋白质相互作用的两个WW结构域。 证据表明，该蛋白质与其他蛋白质结合，从而调节细胞内信号转导，基因表达等，从而参与维持平滑肌细胞的分化。 该蛋白质和调节其表达的化合物在开发用于维持平滑肌细胞分化异常的各种疾病的药物中显着有用。
-
公开(公告)号：US20050214813A1
公开(公告)日：2005-09-29
申请号：US11013400
申请日：2004-12-17
申请人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Hio , Mayako Yamazaki , Susumu Satoh , Hiroyuki Arakawa , Masahiko Morita
发明人： Toshio Ota , Takao Isogai , Tetsuo Nishikawa , Yuri Hio , Mayako Yamazaki , Susumu Satoh , Hiroyuki Arakawa , Masahiko Morita
IPC分类号： A61K38/00 , A61P25/00 , A61P25/28 , C07K14/47 , C07K14/505 , C07K14/52 , C12N1/15 , C12N1/19 , C12N1/21 , C12N15/12 , C12N15/16 , C12P21/08 , C12Q1/68 , C07H21/04 , C12N9/64
CPC分类号： C07K14/4702 , A01K2217/05 , A61K38/00 , C07K14/4711 , C07K14/4747 , C07K14/505 , C07K14/524
摘要： The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-β protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-β protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-β protein.
摘要翻译： 本发明提供：抑制或促进淀粉样蛋白-β蛋白的聚集或沉积的蛋白质; 编码蛋白质的多核苷酸; 筛选抑制或促进淀粉样蛋白-β蛋白的聚集或沉积的化合物的方法; 以及用于治疗或预防阿尔茨海默病的治疗剂，其包含调节蛋白质抑制或促进淀粉样蛋白-β蛋白的聚集或沉积的活性的化合物。
-
-
-
-
-
-
-
-
-
搜索结果
35 条记录 (耗时 0.106 秒)
